CCTS Newsletter Dale Dirks and Dane Christiansen
May 5, 2017
The first week of May, Congress completed work on the eleven outstanding fiscal year (FY) 2017 spending measures by passing an omnibus appropriations package ahead of the expiration of a short-term Continuing Resolution. Just weeks before the appropriations package was passed, citizen scientists were on Capitol Hill for the Translational Science 2017 Advocacy Day to call on their legislators to finalize FY 2017 spending and provide meaningful increases for clinical and translational research and training/career development programs.
The efforts of volunteer community advocates (representing both established and young investigators across the country) to educate their Members of Congress about the full spectrum of medical research and the local impact were, once again, successful. In addition to increasing funding for the National Institutes of Health, and key research programs, the omnibus package also includes specific language protecting the CTSA program and the awards/number of sites. Below, please find a summary of key items from the FY 2017 omnibus package:
$34.1 billion for the NIH, an increase of $2 billion over FY 2016.
$2.65 billion for the National Institute of General Medical Sciences at NIH (which houses the IDeA program), an increase of $138.77 million over FY 2016.
$289.1 million for the National Institute on Minority Health and Health Disparities at NIH (which houses the RCMI program), an increase of $9.35 million over FY 2016.
$1.66 billion for the Office of the Director at NIH, an increase of $106.58 million over FY 2016.
$705.9 million for the National Center for Advancing Translational Sciences at NIH (which houses the CTSA program), an increase of $20.49 million over FY 2016.
Language protecting CTSAs
Clinical and Translational Science Awards (CTSA) Program.-The agreement includes additional funding for the CTSA program to ensure that recommendations from the 2013 Institute of Medicine report can be implemented without reducing the total number of CTSA awards. The agreement directs NCATS to maintain the number of CTSA awards-including the number of clinical and translational research institutions-at no less than the fiscal year 2016 level.
During this tumultuous and uncertain political time, the important role of the citizen scientist and the volunteer advocate has never been clearer. In addition to advancing science, it is important to educate policymakers on Capitol Hill about contemporary topics to ensure adequate support for medical research and the training/career development pipeline. If you would like to know more about making your voice heard, advocating for the community, or simply the details of the FY 2017 appropriations package, please join our May advocacy call:
Coalition for Clinical and Translational Science
May Advocacy Call Monday, May 22nd, 2017 4:00 PM – 4:30 PM (Eastern Time) Dial-in number: 1 (800) 944-8766 Participant Passcode: 79743#